Skip to main content
Wolters Kluwer - PMC COVID-19 Collection logoLink to Wolters Kluwer - PMC COVID-19 Collection
. 2021 Feb 4;52(3):957–965. doi: 10.1161/STROKEAHA.120.032273

Green Tea and Coffee Consumption and All-Cause Mortality Among Persons With and Without Stroke or Myocardial Infarction

Masayuki Teramoto 1, Isao Muraki 1, Kazumasa Yamagishi 2, Akiko Tamakoshi 3, Hiroyasu Iso 1,2,
PMCID: PMC7903984  PMID: 33535784

Supplemental Digital Content is available in the text.

Keywords: coffee, cohort study, diet, green tea, myocardial infarction, prognosis, stroke

Abstract

Background and Purpose:

The effect of green tea and coffee consumption on mortality among cardiovascular diseases survivors is unknown. We examined the association between green tea and coffee consumption and mortality among persons with and without stroke or myocardial infarction (MI).

Methods:

In the Japan Collaborative Cohort Study, 46 213 participants (478 stroke survivors, 1214 MI survivors, and 44 521 persons without a history of stroke or MI), aged 40 to 79 years at baseline (1988–1990), completed a lifestyle, diet, and medical history questionnaire and were followed up regarding mortality until 2009. The Cox proportional hazard model was used to calculate the multivariable hazard ratios with 95% CIs of all-cause mortality after adjusting for potential confounding factors.

Results:

During the 18.5-year median follow-up period, 9253 cases were documented. Green tea consumption was inversely associated with all-cause mortality among stroke or MI survivors; the multivariable hazard ratios (95% CIs) for stroke survivors were 0.73 (0.42–1.27) for 1 to 6 cups/wk, 0.65 (0.36–1.15) for 1 to 2 cups/d, 0.56 (0.34–0.92) for 3 to 4 cups/d, 0.52 (0.31–0.86) for 5 to 6 cups/d, and 0.38 (0.20–0.71) for ≥7 cups/d, compared with nondrinkers. A similar inverse association was observed for MI survivors, but not evident for those without a history of stroke or MI. Coffee consumption was inversely associated with all-cause mortality in persons without a history of stroke or MI; the multivariable hazard ratios (95% CIs) were 0.86 (0.82–0.91) for 1 to 6 cups/wk, 0.86 (0.80–0.92) for 1 cup/d, and 0.82 (0.77–0.89) for ≥2 cups/d, compared with nondrinkers. The corresponding hazard ratios (95% CIs) for MI survivors were 0.69 (0.53–0.91), 0.78 (0.55–1.10), and 0.61 (0.41–0.90). No such association was observed for stroke survivors.

Conclusions:

Green tea consumption can be beneficial in improving the prognosis for stroke or MI survivors, whereas coffee consumption can also be so for persons without a history of stroke or MI as well as MI survivors.


Green tea is one of the most commonly consumed beverages in Asia and has been extensively studied for its protective effect on chronic diseases, including cardiovascular diseases (CVD).1,2 Mineharu et al1 previously showed that those who consumed 3 to 5 cups/d of green tea had a 41% lower CVD mortality compared with nondrinkers of green tea in the general Japanese population. These beneficial effects of green tea consumption have also been reported in a recent meta-analysis.2

Moreover, coffee is a popular beverage worldwide and has been examined for its potential to reduce mortalities in the general population.1,35 Meta-analyses have concluded that moderate coffee consumption was associated with a lower risk of all-cause and CVD mortality in the general population.4,5

Among myocardial infarction (MI) survivors, the consumption of caffeinated tea, which included both black and green teas, was associated with reduced CVD mortality,6 but the consumption of caffeinated coffee was not associated with the risk of cardiovascular events7 or all-cause mortality.8 This suggests that the consumption of tea and coffee may have different impacts on the prognosis of patients with CVD. To the best of our knowledge, no data are available on the association between green tea intake and subsequent mortality among MI survivors. No previous studies have examined the associations of green tea and coffee consumption among stroke survivors.

With an aging population and improvement in the case fatality rate of stroke or MI, scientific evidence focusing on the lifestyles of stroke or MI survivors has been garnering interest.9 Therefore, the objective of the present study was to examine and compare the association of green tea and coffee consumption in relation to all-cause mortality among persons with and without a history of stroke or MI, using the data of a large long-term cohort study of Japanese men and women.

Methods

The data that support the findings of this study are available from the corresponding author upon reasonable request.

Study Population

The JACC study (Japan Collaborative Cohort Study for Evaluation of Cancer Risk) is a large nationwide community-based prospective study that started between 1988 and 1990 and enrolled 110 585 individuals (46 395 men and 64 190 women) aged 40 to 79 years, living in 45 communities across Japan. The methodology of the JACC study has been described elsewhere.10 Briefly, a total of 110 585 participants were asked to complete self-administered questionnaires, including demographic characteristics, medical history, lifestyle, and diet. According to self-reported history of stroke and MI, we classified participants into 3 groups: history of stroke, history of MI, and no history of stroke or MI.

From 110 585 cohort participants, we excluded 3423 participants (1423 men and 2000 women) living in 2 communities because the questions on the frequency of green tea or coffee consumption were not included in the questionnaire (Figure I in the Data Supplement). We also excluded 17 243 daily green tea or coffee drinkers (7636 men and 9607 women) living in 12 communities because the questions on the number of cups of green tea and coffee consumed per day were not included in the questionnaire. Subsequently, we excluded 12 299 participants (4855 men and 7444 women) owing to missing information on history of stroke or MI. Furthermore, 962 participants (287 men and 675 women) who reported a history of cancer and 120 participants (73 men and 47 women) who reported both a history of stroke and MI were excluded. Finally, we excluded 30 325 participants (13 519 men and 16 806 women) owing to missing or inappropriate responses to green tea and coffee consumption. A total of 46 213 participants (18 602 men and 27 611 women) were included in the analyses.

Before completing the questionnaire, the participants or community representatives provided informed consent to be involved in this epidemiological study, according to the guidelines of the Council for International Organizations of Medical Sciences. Informed individual consent was obtained from each participant in 36 of the 45 study areas (written consent in 35 areas and oral consent in 1 area). In the remaining 9 areas, group consent was obtained from each area leader. This study protocol was approved by the Ethics Committees of Nagoya University and Osaka University.

Assessment of Green Tea and Coffee Consumption

We asked participants about their frequency and amount of green tea and coffee consumed using the following choices: almost every day, 3 to 4 cups per week, 1 to 2 cups per week, 1 to 2 cups per month, and almost never. For those who answered, almost every day, we further asked questions on the number of cups consumed per day. According to their responses to these 2 questions, we classified their response into 6 levels for green tea consumption (occasionally or none, 1–6 cups/wk, 1–2, 3–4, 5–6, and ≥7 cups/d) and into 4 levels for coffee consumption (occasionally or none, 1–6 cups/wk, 1, and ≥2 cups/d). The type of coffee, such as decaffeinated or caffeinated, was not asked because decaffeinated coffee was not common, and most participants consumed instant or drip brewed coffee during the baseline survey period in Japan. The volume of a typical cup of green tea and coffee was ≈100 and 150 mL, respectively. The validation study of the food frequency questionnaire used in this cohort was conducted during the 1-year follow-up period, indicating a relatively higher correlation coefficient of green tea (Spearman correlation coefficient: 0.62) and coffee (Spearman correlation coefficient: 0.86).11

Assessment of Confounding Variables

Other information on demographic and lifestyle factors was derived from a self-administered questionnaire at baseline: age, sex, height, weight, past medical history (such as diabetes and hypertension), smoking and alcohol drinking status, exercise and walking habits, mental status, educational level, occupation, and eating habits. Body mass index was calculated as body weight (kg) divided by the square of height (m2).

Mortality Surveillance

To obtain the cause of death, a systematic review of death certificates was conducted in each area. Mortality data were sent centrally to the Ministry of Health and Welfare through the local public health center, and the underlying cause of death was coded for the National Vital Statistics according to the International Classification of Diseases, Tenth Revision. In 35 areas, the end of the follow-up was the end of 1999 in 4 areas, the end of 2003 in 4 areas, the end of 2008 in 4 areas, and the end of 2009 in the rest of the areas. The end point of death in this study was all causes. The date of moving from the community was verified using population-registration documents. When participants moved out, we treated them as censored cases.

Statistical Analysis

Person years of follow-up were calculated as the duration from the date of the baseline questionnaire to the date of death, emigration from the community, or the end of follow-up, whichever occurred first. Age-adjusted mean values and proportions of having cardiovascular risk factors were calculated by using the ANCOVA for means and logistic regression for proportion. Hazard ratios with 95% CIs of all-cause mortality were calculated using the Cox proportional hazards regression models according to green tea and coffee consumption. We adjusted for age (continuous), sex (women or men), history of hypertension (yes or no), history of diabetes (yes or no), body mass index (sex-specific quintile), smoking status (never, ex-smoker, current smoker of 1–19, or current smoker of ≥20 cigarettes per day), alcohol consumption (never drinker, ex-drinker, current drinker of 0.1–45.9, or ≥46.0 g ethanol per day), hours of exercise (almost never, 1–4 hours, or ≥5 hours per week), hours of walking (almost never, 0.5 hours, or >0.5 hours per day), perceived mental stress (low, moderate, or high), educational level (≤18 or ≥19 years of age upon completion of education), employment status (unemployed or employed), frequency of consuming vegetables, fish, and fruits, soybean intakes (quintile), and green tea or coffee consumption.

For secondary analyses, we conducted sex-specific analysis and cause-stratified analysis by CVD and cancer. To account for potential bias due to reverse causality, we performed sensitivity analyses by excluding all participants who died during the first 5 years of follow-up. SAS version 9.4 (SAS, Inc, Cary, NC) was used for all statistical analyses. This study followed the Strengthening the Reporting of Observational Studies in Epidemiology statements.12

Results

Age-adjusted baseline characteristics of the participants were presented according to green tea consumption in Table 1. Persons with more frequent green tea consumption were more likely to eat fish, fruits, and soybeans regardless of a history of stroke or MI. Among persons without a history of stroke or MI, frequent green tea consumption was associated with a lower prevalence of diabetes.

Table 1.

Age-Adjusted Baseline Characteristics of Participants According to Green Tea Consumption

graphic file with name str-52-957-g001.jpg

Table 2 shows the age-adjusted baseline characteristics of the participants according to coffee consumption. Persons with more frequent coffee consumption were more likely to be younger, current smokers, current drinkers, and less unemployed, regardless of a history of stroke or MI. Among MI survivors, coffee consumption was associated with a lower intake of vegetables and soybeans. In addition, among persons without a history of stroke or MI, frequent coffee consumption was associated with a lower prevalence of hypertension and diabetes, higher mental stress, higher educational level, less intake of fish, and more frequent walking.

Table 2.

Age-Adjusted Baseline Characteristics of Participants According to Coffee Consumption

graphic file with name str-52-957-g002.jpg

Risk of All-Cause Mortality According to Green Tea Consumption

During the 18.5 years of median follow-up, a total of 9253 deaths were documented. In age- and sex-adjusted analyses, green tea consumption was associated with lower risks of all-cause mortality among persons with and without a history of stroke or MI (Table 3). After further adjustment for potential confounding factors, the association was attenuated among persons without a history of stroke or MI, while the association remained among persons with a history of stroke or MI. The multivariable hazard ratios of all-cause mortality among persons with a history of stroke were 0.73 (95% CI, 0.42–1.27) for 1 to 6 cups/wk, 0.65 (95% CI, 0.36–1.15) for 1 to 2 cups/d, 0.56 (95% CI, 0.34–0.92) for 3 to 4 cups/d, 0.52 (95% CI, 0.31–0.86) for 5 to 6 cups/d, and 0.38 (95% CI, 0.20–0.71) for ≥7 cups/d (P for trend=0.002) compared with nondrinkers. A similar inverse association was observed among persons with a history of MI. These inverse associations were similarly observed between men and women among persons with a history of stroke but were observed only among men with a history of MI (Table I in the Data Supplement). The reduced all-cause mortality among persons with a history of stroke or MI was primarily due to CVD mortality (Table II in the Data Supplement). In the sensitivity analyses, the exclusion of all participants who died during the first 5 years of follow-up (n=1439) did not change the results materially (Table III in the Data Supplement).

Table 3.

Hazard Ratios (95% CIs) of All-Cause Mortality According to Green Tea Consumption

graphic file with name str-52-957-g003.jpg

Risk of All-Cause Mortality According to Coffee Consumption

Coffee consumption was inversely associated with the risk of all-cause mortality among persons without a history of stroke or MI (Table 4). Additional adjustment for potential confounding factors did not change the inverse associations. The multivariable hazard ratios of all-cause mortality among persons without a history of stroke or MI were 0.86 (95% CI, 0.82–0.91) for 1 to 6 cups/wk, 0.86 (95% CI, 0.80–0.92) for 1 cup/d, and 0.82 (95% CI, 0.77–0.89) for ≥2 cups/d (P for trend <0.001) compared with nondrinkers. Among persons with a history of stroke, no significant association between coffee consumption and all-cause mortality was found. Among persons with a history of MI, coffee consumption was associated with a reduced risk of all-cause mortality. The reduced all-cause mortality among persons with a history of MI was observed between men and women (Table IV in the Data Supplement) and was primarily due to CVD mortality (Table V in the Data Supplement). In the sensitivity analyses, similar associations were observed among persons with a history of MI and without a history of stroke or MI when all participants who died during the first 5 years of follow-up were excluded (Table VI in the Data Supplement).

Table 4.

Hazard Ratios (95% CIs) of All-Cause Mortality According to Coffee Consumption

graphic file with name str-52-957-g004.jpg

Discussion

In this large prospective study of Japanese men and women aged 40 to 79 years with the median follow-up of 18.5 years, we observed that stroke survivors who consumed ≥7 cups/d of green tea had ≈60% lower risks of all-cause mortality than those who rarely consumed green tea, while such an association was not observed among persons without a history of stroke or MI. To the best of our knowledge, this is the first to find the associations of green tea consumption with all-cause mortality among stroke survivors. Our results suggest a beneficial effect of green tea consumption on patients’ health outcomes after CVD events.

In addition, an inverse association of coffee consumption in relation to all-cause mortality was observed among persons without a history of stroke or MI and with a history of MI, but not among stroke survivors. Our findings on the suggestive inverse association between coffee consumption and the risk of all-cause mortality among MI survivors are consistent with findings from previous studies in Western countries. A cohort study of 1369 patients hospitalized with a confirmed first acute MI in Sweden showed that coffee consumption was associated with a lower risk of subsequent all-cause mortality after MI: the multivariable hazard ratios were 0.68 (95% CI, 0.45–1.02) for persons who consumed 1 to 3 cups/d, 0.56 (95% CI, 0.37–0.85) for 3 to 5 cups/d, 0.52 (95% CI, 0.34–0.83) for 5 to 7 cups/d, and 0.58 (95% CI, 0.34–0.98) for ≥7 cups/d, compared with those who consumed <1 cup.13 Another cohort study of 4365 Dutch MI patients, clinically diagnosed 10 years before study enrollment, showed a borderline inverse association between coffee consumption and the risk of all-cause mortality among individuals who consumed ≥2 to 4 cups of coffee/d, compared with nondrinkers; the multivariable hazard ratio was 0.84 (95% CI, 0.71–1.00).14

A potential mechanism for the influence of green tea on cardiovascular health can be primarily attributed to the effect of (−)-epigallocatechin3-gallate, which is the most abundant polyphenol in green tea.15 Previous experimental research revealed the cardiovascular health promoting effects of (−)-epigallocatechin3-gallate, such as alleviating atherosclerosis,16,17 ameliorating ischemia/reperfusion injury,18,19 enhancing endothelial function,20,21 and attenuating inflammation.2224 Previous animal studies showed that (−)-epigallocatechin3-gallate exerted a neuro-protective effect against ischemic damage in the acute phase of ischemic stroke25,26 and had a long-term effect of promoting neurogenesis after stroke,27 which suggests that green tea consumption can contribute, not only to an improvement in prognosis among stroke survivors but also to patients’ functional recovery after stroke.

Moreover, caffeinated coffee consumption was associated with lower serum cholesterol levels,28 improved endothelial function (lowering E-selectin levels), and reduced inflammation (lowering C-reactive protein levels) in diabetic women.29 Coffee intake was also associated with higher plasma adiponectin concentrations in women with or without type 2 diabetes.30 The underlying mechanisms concerning the lack of an association between coffee consumption and mortality among stroke survivors are uncertain. One hypothesis is that daily coffee consumption might lead to an increment in blood pressure among stroke survivors. A previous meta-analysis reported that chronic caffeinated coffee consumption was associated with higher systolic and diastolic blood pressure levels,31 whereas green tea consumption was associated with lower blood pressure levels.32 Further studies are necessary to explore the mediating factors of the association between coffee consumption and mortality among stroke survivors.

The strength of the present study is the prospective study design minimizing recall bias of the exposure assessment and a large sample size of stroke and MI survivors. However, this study has several limitations.

First, because histories of stroke or MI and consumption of green tea or coffee were self-reported, false reporting can be a potential problem. Second, we did not have information on behavioral changes over time, although green tea and coffee consumption might have changed during the long follow-up period. Nondifferential misclassification could result in a potential underestimation of the association between green tea or coffee consumption and mortality outcome. Finally, since the present study is an observational study, the causality of the consumption of green tea and coffee in relation to protective cardiovascular health cannot be determined.

Conclusions

Green tea consumption was inversely associated with all-cause mortality, especially among stroke or MI survivors but not in persons without a history of stroke or MI. Coffee consumption was inversely associated with all-cause mortality among persons without a history of stroke or MI as well as with a history of MI. Our observational study suggests that green tea consumption can be beneficial for the secondary prevention of CVD, whereas coffee consumption can also be so for primary prevention. More research is needed to confirm the cardio- and neuro-protective effects of green tea and coffee among CVD survivors.

Acknowledgments

We thank all staff members involved in this study for their valuable help in conducting the baseline survey and follow-up.

Sources of Funding

This study has been supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT; MonbuKagaku-sho); Grants-in-Aid for Scientific Research on Priority Areas of Cancer; and Grants-in-Aid for Scientific Research on Priority Areas of Cancer Epidemiology from MEXT (Nos. 61010076, 62010074, 63010074, 1010068, 2151065, 3151064, 4151063, 5151069, 6279102, 11181101, 17015022, 18014011, 20014026, 20390156, 26293138), and Grant-in-Aid for Scientific Research on Innovative Areas from MEXT (No. 16H06277). This research was also supported by Grant–in–Aid from the Ministry of Health, Labour and Welfare, Health and Labor Sciences research grants, Japan (Comprehensive Research on Cardiovascular Disease and Lifestyle Related Diseases: H20–Junkankitou [Seishuu]–Ippan–013; H23–Junkankitou [Seishuu]–Ippan–005); an Intramural Research Fund (22-4-5) for Cardiovascular Diseases of National Cerebral and Cardiovascular Center; Comprehensive Research on Cardiovascular Diseases and Lifestyle Related Diseases (H26-Junkankitou [Seisaku]-Ippan-001) and H29–Junkankitou [Seishuu]–Ippan–003 and 20FA1002.

Disclosures

None.

Supplemental Materials

Tables I–VI

Figure I

Supplementary Material

str-52-957-s001.pdf (306.5KB, pdf)

Footnotes

Nonstandard Abbreviations and Acronyms

CVD
cardiovascular disease
JACC
Japan Collaborative Cohort Study for Evaluation of Cancer Risk
MI
myocardial infarction

The Data Supplement is available with this article at https://www.ahajournals.org/doi/suppl/10.1161/STROKEAHA.120.032273.

For Sources of Funding and Disclosures, see page 964.

Contributor Information

Masayuki Teramoto, Email: m.teramoto0715@gmail.com.

Isao Muraki, Email: muraki@pbhel.med.osaka-u.ac.jp.

Kazumasa Yamagishi, Email: yamagishi.kazumas.ge@u.tsukuba.ac.jp.

Akiko Tamakoshi, Email: tamaa@med.hokudai.ac.jp.

References

  • 1.Mineharu Y, Koizumi A, Wada Y, Iso H, Watanabe Y, Date C, Yamamoto A, Kikuchi S, Inaba Y, Toyoshima H, et al. ; JACC study Group. Coffee, green tea, black tea and oolong tea consumption and risk of mortality from cardiovascular disease in Japanese men and women. J Epidemiol Community Health. 2011; 65:230–240. doi: 10.1136/jech.2009.097311 [DOI] [PubMed] [Google Scholar]
  • 2.Tang J, Zheng JS, Fang L, Jin Y, Cai W, Li D. Tea consumption and mortality of all cancers, CVD and all causes: a meta-analysis of eighteen prospective cohort studies. Br J Nutr. 2015; 114:673–683. doi: 10.1017/S0007114515002329 [DOI] [PubMed] [Google Scholar]
  • 3.Freedman ND, Park Y, Abnet CC, Hollenbeck AR, Sinha R. Association of coffee drinking with total and cause-specific mortality. N Engl J Med. 2012; 366:1891–1904. doi: 10.1056/NEJMoa1112010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Ding M, Bhupathiraju SN, Satija A, van Dam RM, Hu FB. Long-term coffee consumption and risk of cardiovascular disease: a systematic review and a dose-response meta-analysis of prospective cohort studies. Circulation. 2014; 129:643–659. doi: 10.1161/CIRCULATIONAHA.113.005925 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Kim Y, Je Y, Giovannucci E. Coffee consumption and all-cause and cause-specific mortality: a meta-analysis by potential modifiers. Eur J Epidemiol. 2019; 34:731–752. doi: 10.1007/s10654-019-00524-3 [DOI] [PubMed] [Google Scholar]
  • 6.Mukamal KJ, Maclure M, Muller JE, Sherwood JB, Mittleman MA. Tea consumption and mortality after acute myocardial infarction. Circulation. 2002; 105:2476–2481. doi: 10.1161/01.cir.0000017201.88994.f7 [DOI] [PubMed] [Google Scholar]
  • 7.Silletta MG, Marfisi R, Levantesi G, Boccanelli A, Chieffo C, Franzosi M, Geraci E, Maggioni AP, Nicolosi G, Schweiger C, et al. ; GISSI-Prevenzione Investigators. Coffee consumption and risk of cardiovascular events after acute myocardial infarction: results from the GISSI (Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico)-Prevenzione trial. Circulation. 2007; 116:2944–2951. doi: 10.1161/CIRCULATIONAHA.107.712976 [DOI] [PubMed] [Google Scholar]
  • 8.Mukamal KJ, Maclure M, Muller JE, Sherwood JB, Mittleman MA. Caffeinated coffee consumption and mortality after acute myocardial infarction. Am Heart J. 2004; 147:999–1004. doi: 10.1016/j.ahj.2003.12.038 [DOI] [PubMed] [Google Scholar]
  • 9.Feigin VL, Norrving B, Mensah GA. Global burden of stroke. Circ Res. 2017; 120:439–448. doi: 10.1161/CIRCRESAHA.116.308413 [DOI] [PubMed] [Google Scholar]
  • 10.Tamakoshi A, Ozasa K, Fujino Y, Suzuki K, Sakata K, Mori M, Kikuchi S, Iso H, Sakauchi F, Motohashi Y, et al. ; JACC Study Group. Cohort profile of the Japan collaborative cohort study at final follow-up. J Epidemiol. 2013; 23:227–232. doi: 10.2188/jea.je20120161 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Date C, Fukui M, Yamamoto A, Wakai K, Ozeki A, Motohashi Y, Adachi C, Okamoto., Kurosawa M, Tokudome Y, et al. Reproducibility and validity of a self-administered food frequency questionnaire used in the JACC study. J Epidemiol. 2005; 1:S9–S23. doi: 10.2188/jea.15.S9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007; 370:1453–1457. doi: 10.1016/S0140-6736(07)61602-X [DOI] [PubMed] [Google Scholar]
  • 13.Mukamal KJ, Hallqvist J, Hammar N, Ljung R, Gémes K, Ahlbom A, Ahnve S, Janszky I. Coffee consumption and mortality after acute myocardial infarction: the Stockholm heart epidemiology program. Am Heart J. 2009; 157:495–501. doi: 10.1016/j.ahj.2008.11.009 [DOI] [PubMed] [Google Scholar]
  • 14.van Dongen LH, Mölenberg FJ, Soedamah-Muthu SS, Kromhout D, Geleijnse JM. Coffee consumption after myocardial infarction and risk of cardiovascular mortality: a prospective analysis in the Alpha Omega Cohort. Am J Clin Nutr. 2017; 106:1113–1120. doi: 10.3945/ajcn.117.153338 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Graham HN. Green tea composition, consumption, and polyphenol chemistry. Prev Med. 1992; 21:334–350. doi: 10.1016/0091-7435(92)90041-f [DOI] [PubMed] [Google Scholar]
  • 16.Yin J, Huang F, Yi Y, Yin L, Peng D. EGCG attenuates atherosclerosis through the Jagged-1/Notch pathway. Int J Mol Med. 2016; 37:398–406. doi: 10.3892/ijmm.2015.2422 [DOI] [PubMed] [Google Scholar]
  • 17.Wang W, Zhang ZZ, Wu Y, Wang RQ, Chen JW, Chen J, Zhang Y, Chen YJ, Geng M, Xu ZD, et al. (-)-Epigallocatechin-3-Gallate ameliorates atherosclerosis and modulates hepatic lipid metabolic gene expression in apolipoprotein E knockout mice: involvement of TTC39B. Front Pharmacol. 2018; 9:195 doi: 10.3389/fphar.2018.00195 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Othman AI, Elkomy MM, El-Missiry MA, Dardor M. Epigallocatechin-3-gallate prevents cardiac apoptosis by modulating the intrinsic apoptotic pathway in isoproterenol-induced myocardial infarction. Eur J Pharmacol. 2017; 794:27–36. doi: 10.1016/j.ejphar.2016.11.014 [DOI] [PubMed] [Google Scholar]
  • 19.Salameh A, Schuster R, Daehnert I, Seeger J, Dhein S. Epigallocatechin gallate reduces ischemia/reperfusion injury in isolated perfused rabbit hearts. Int J Mol Sci. 2018; 19:628 doi: 10.3390/ijms19020628 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Liu SM, Sun ZW, Chu P, Li HL, Ahsan A, Zhou ZR, Zhang ZH, Sun B, Wu JJ, Xi YL, et al. EGCG protects against homocysteine-induced human umbilical vein endothelial cells apoptosis by modulating mitochondrial-dependent apoptotic signaling and PI3K/Akt/eNOS signaling pathways. Apoptosis. 2017; 22:672–680. doi: 10.1007/s10495-017-1360-8 [DOI] [PubMed] [Google Scholar]
  • 21.Zhan XL, Yang XH, Gu YH, Guo LL, Jin HM. Epigallocatechin gallate protects against homocysteine-induced vascular smooth muscle cell proliferation. Mol Cell Biochem. 2018; 439:131–140. doi: 10.1007/s11010-017-3142-6 [DOI] [PubMed] [Google Scholar]
  • 22.Oyama JI, Shiraki A, Nishikido T, Maeda T, Komoda H, Shimizu T, Makino N, Node K. EGCG, a green tea catechin, attenuates the progression of heart failure induced by the heart/muscle-specific deletion of MnSOD in mice. J Cardiol. 2017; 69:417–427. doi: 10.1016/j.jjcc.2016.05.019 [DOI] [PubMed] [Google Scholar]
  • 23.Zhao J, Liu J, Pang X, Zhang X, Wang S, Wu D. Epigallocatechin-3-gallate inhibits angiotensin II-induced C-reactive protein generation through interfering with the AT1-ROS-ERK1/2 signaling pathway in hepatocytes. Naunyn Schmiedebergs Arch Pharmacol. 2016; 389:1225–1234. doi: 10.1007/s00210-016-1279-6 [DOI] [PubMed] [Google Scholar]
  • 24.Wang TF, Xiang ZM, Wang Y, Li X, Fang CY, Song S, Li CL, Yu HS, Wang H, Yan L, et al. (−)-Epigallocatechin gallate targets Notch to attenuate the inflammatory response in the immediate early stage in human macrophages. Front Immunol. 2017; 8:433 doi: 10.3389/fimmu.2017.00433 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Yao C, Zhang J, Liu G, Chen F, Lin Y. Neuroprotection by (-)-epigallocatechin-3-gallate in a rat model of stroke is mediated through inhibition of endoplasmic reticulum stress. Mol Med Rep. 2014; 9:69–76. doi: 10.3892/mmr.2013.1778 [DOI] [PubMed] [Google Scholar]
  • 26.Zhang F, Li N, Jiang L, Chen L, Huang M. Neuroprotective effects of (-)-epigallocatechin-3-gallate against focal cerebral ischemia/reperfusion injury in rats through attenuation of inflammation. Neurochem Res. 2015; 40:1691–1698. doi: 10.1007/s11064-015-1647-5 [DOI] [PubMed] [Google Scholar]
  • 27.Zhang JC, Xu H, Yuan Y, Chen JY, Zhang YJ, Lin Y, Yuan SY. Delayed treatment with green tea polyphenol EGCG promotes neurogenesis after ischemic stroke in adult mice. Mol Neurobiol. 2017; 54:3652–3664. doi: 10.1007/s12035-016-9924-0 [DOI] [PubMed] [Google Scholar]
  • 28.Jee SH, He J, Appel LJ, Whelton PK, Suh I, Klag MJ. Coffee consumption and serum lipids: a meta-analysis of randomized controlled clinical trials. Am J Epidemiol. 2001; 153:353–362. doi: 10.1093/aje/153.4.353 [DOI] [PubMed] [Google Scholar]
  • 29.Lopez-Garcia E, van Dam RM, Qi L, Hu FB. Coffee consumption and markers of inflammation and endothelial dysfunction in healthy and diabetic women. Am J Clin Nutr. 2006; 84:888–893. doi: 10.1093/ajcn/84.4.888 [DOI] [PubMed] [Google Scholar]
  • 30.Williams CJ, Fargnoli JL, Hwang JJ, van Dam RM, Blackburn GL, Hu FB, Mantzoros CS. Coffee consumption is associated with higher plasma adiponectin concentrations in women with or without type 2 diabetes: a prospective cohort study. Diabetes Care. 2008; 31:504–507. doi: 10.2337/dc07-1952 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Jee SH, He J, Whelton PK, Suh I, Klag MJ. The effect of chronic coffee drinking on blood pressure: a meta-analysis of controlled clinical trials. Hypertension. 1999; 33:647–652. doi: 10.1161/01.hyp.33.2.647 [DOI] [PubMed] [Google Scholar]
  • 32.Peng X, Zhou R, Wang B, Yu X, Yang X, Liu K, Mi M. Effect of green tea consumption on blood pressure: a meta-analysis of 13 randomized controlled trials. Sci Rep. 2014; 4:6251 doi: 10.1038/srep06251 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

str-52-957-s001.pdf (306.5KB, pdf)

Articles from Stroke are provided here courtesy of Wolters Kluwer Health

RESOURCES